Register information Protection certificate

DE file number : 12 2013 000 016.3 (Status: not pending/lapsed, Query started: July 25, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTNot pending/lapsed
21DE file number DAKZ12 2013 000 016.3
UseVZMedicinal products
95Product nameTIEZAxitinib, gegebenenfalls in Form eines pharmazeutisch annehmbaren Salzes
54Title of basic patentTIGZINDAZOL-VERBINDUNGEN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR HEMMUNG VON PROTEINKINASEN UND VERFAHREN ZU IHRER VERWENDUNG
51IPC main classICM
(ICMV)		 C07D 231/56 (2006.01)
94Start of term of protectionLBJul 1, 2020
94End of term of protectionLEJun 30, 2025
22DE application dateDATFeb 19, 2013
Date of publication of application for a certificateOTMay 2, 2013
Date of publication of grant of certificatePETJan 26, 2017
71/73Applicant/ownerINHAgouron Pharmaceuticals, LLC, San Diego, Calif., US
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
Patent division in charge 44
68DE file number of basic patentGAKZ600 36 879.3
68EP file number of basic patentGEAKZ00 94 3375.6
43Date of first publicationEVTMay 2, 2013
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/12/777/001-006
2012-09-03
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/12/777/001-006
2012-09-03
Date of the first transfer into DPMAregisterEREGTMay 2, 2013
Date of the (most recent) update in DPMAregisterREGTJul 2, 2025
(Show all update days)(Hide all update days)
  • Jul 2, 2025
    • Status: changed
    • Procedures: Administrative procedure, IP right lapsed through expiry of term of protection, 30.06.2025: new
  • Jul 24, 2024
    • St.36: changed (technical change)
  • May 2, 2013
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Mar 8, 2013 May 2, 2013 Details anzeigen
2 New applicant/owner details New applicant/owner details Mar 8, 2013  Details anzeigen
3 Supplementary protection certificate procedure Decision to grant supplementary protection certificate by Patent Division Oct 5, 2016  Details anzeigen
4 Supplementary protection certificate procedure Supplementary protection certificate granted Nov 11, 2016 Jan 26, 2017 Details anzeigen
5 New applicant/owner details New applicant/owner details Oct 18, 2017  Details anzeigen
6 New representative details New representative details Mar 6, 2024  Details anzeigen
7 Administrative procedure IP right lapsed through expiry of term of protection Jun 30, 2025  Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTMar 8, 2013
Issue numberHN18
YearPJ2013
Publication dateVTMay 2, 2013
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ600 36 879.3
68EP file number of basic patentGEAKZ00 94 3375.6
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMar 8, 2013
71/73Applicant/ownerINHAgouron Pharmaceuticals, Inc., San Diego, Calif., US
71/73Previous applicant/ownerINHFAgouron Pharmaceuticals, Inc., San Diego, Calif., US
View procedures Supplementary protection certificate procedure (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTDecision to grant supplementary protection certificate by Patent Division
Date of legal/procedural statusVSTTOct 5, 2016
View procedures Supplementary protection certificate procedure (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTSupplementary protection certificate granted
Date of legal/procedural statusVSTTNov 11, 2016
Issue numberHN4
YearPJ2017
Publication dateVTJan 26, 2017
Type of publicationPARTBibliographic data
PartHTPart 7
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTOct 18, 2017
71/73Applicant/ownerINHAgouron Pharmaceuticals, LLC, San Diego, Calif., US
71/73Previous applicant/ownerINHFAgouron Pharmaceuticals, Inc., San Diego, Calif., US
View procedures New representative details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew representative details
Legal/procedural statusVSTNew representative details
Date of legal/procedural statusVSTTMar 6, 2024
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
74Previous representativeVTRFLederer & Keller Patentanwälte Partnerschaft mbB, 80538 München, DE
Date of update of the procedureREGTMar 7, 2024
View procedures Administrative procedure (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTAdministrative procedure
Legal/procedural statusVSTIP right lapsed through expiry of term of protection
Date of legal/procedural statusVSTTJun 30, 2025
Date of update of the procedureREGTJul 2, 2025